Insider Buying: Shoulder Innovations (NYSE:SI) CEO Acquires 2,000 Shares of Stock

Key Points

• Shoulder Innovations CEO Robert Joseph Ball bought 2,000 shares of company stock at an average price of $14.90, totaling $29,800, and now owns 105,259 shares valued at approximately $1,568,359.10.
• In a subsequent transaction, Ball purchased an additional 6,000 shares at an average price of $15.49 each, amounting to $92,940.
• Analysts have rated Shoulder Innovations with a consensus of "Moderate Buy" and an average target price of $19.60, with multiple firms assigning buy ratings.

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CEO Robert Joseph Ball purchased 2,000 shares of the business's stock in a transaction on Thursday, September 11th. The stock was purchased at an average cost of $14.90 per share, with a total value of $29,800.00. Following the completion of the acquisition, the chief executive officer owned 105,259 shares in the company, valued at approximately $1,568,359.10. This trade represents a 1.94% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

Robert Joseph Ball also recently made the following trade(s):

• On Friday, September 12th, Robert Joseph Ball purchased 6,000 shares of Shoulder Innovations stock. The stock was purchased at an average cost of $15.49 per share, with a total value of $92,940.00.

Shoulder Innovations Price Performance

NYSE:SI traded down $0.74 during trading hours on Monday, hitting $14.97. The stock had a trading volume of 78,248 shares, compared to its average volume of 173,990. Shoulder Innovations, Inc. has a one year low of $11.75 and a one year high of $17.94. The company has a market cap of $227.99 million and a price-to-earnings ratio of -0.50.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. The Goldman Sachs Group assumed coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They issued a "buy" rating and a $20.00 target price for the company. Piper Sandler assumed coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They issued an "overweight" rating and a $18.00 target price for the company. Zacks Research upgraded shares of Shoulder Innovations to a "hold" rating in a research report on Tuesday, August 26th. Wall Street Zen upgraded shares of Shoulder Innovations from a "sell" rating to a "hold" rating in a research report on Saturday. Finally, Jefferies Financial Group started coverage on shares of Shoulder Innovations in a research note on Monday, August 25th. They issued a "buy" rating and a $19.00 price target for the company. Five investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $19.60.

Shoulder Innovations Company Profile

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.